Orchestra BioMed Holdings Gross Margin Growth & History (OBIO)

Orchestra BioMed Holdings's gross margin was 99.43% for fiscal 2025.

View full Orchestra BioMed Holdings company overview

Orchestra BioMed Holdings annual gross margin history

Orchestra BioMed Holdings annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3199.43%+7.17 pp
20242024-12-3192.27%−0.99 pp
20232023-12-3193.26%−0.77 pp
20222022-12-3194.03%

Orchestra BioMed Holdings gross margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Orchestra BioMed Holdings's gross margin increased from 94.03% to 99.43%, a change of +5.40 percentage points. The latest reported quarter, Q2 2026, shows 71.59%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Orchestra BioMed Holdings source filings ↗

Community posts

It’s quiet here.

No posts about OBIO yet. Start the conversation.

Write the first post